BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,311 | -17.6% | 11,223 | 0.0% | 0.10% | -14.4% |
| Q2 2023 | $511,320 | +12.3% | 11,223 | 0.0% | 0.11% | -0.9% |
| Q1 2023 | $455,205 | +50.8% | 11,223 | +89.5% | 0.11% | +34.9% |
| Q4 2022 | $301,895 | -6.8% | 5,923 | 0.0% | 0.08% | -8.8% |
| Q3 2022 | $324,000 | -14.7% | 5,923 | 0.0% | 0.09% | -13.3% |
| Q2 2022 | $380,000 | -17.2% | 5,923 | 0.0% | 0.10% | 0.0% |
| Q1 2022 | $459,000 | -11.9% | 5,923 | 0.0% | 0.10% | -13.9% |
| Q4 2021 | $521,000 | -45.3% | 5,923 | -50.0% | 0.12% | +19.6% |
| Q3 2021 | $952,000 | +100.0% | 11,846 | +100.0% | 0.10% | -23.9% |
| Q2 2021 | $476,000 | -4.6% | 5,923 | 0.0% | 0.13% | -15.7% |
| Q1 2021 | $499,000 | +5.1% | 5,923 | 0.0% | 0.16% | -9.1% |
| Q4 2020 | $475,000 | -0.2% | 5,923 | 0.0% | 0.18% | -12.9% |
| Q3 2020 | $476,000 | -6.7% | 5,923 | 0.0% | 0.20% | -19.0% |
| Q2 2020 | $510,000 | +6.0% | 5,923 | 0.0% | 0.25% | -24.2% |
| Q1 2020 | $481,000 | -28.3% | 5,923 | -22.7% | 0.33% | -19.7% |
| Q3 2019 | $671,000 | +85.9% | 7,666 | +73.7% | 0.41% | +69.6% |
| Q2 2019 | $361,000 | +0.6% | 4,413 | 0.0% | 0.24% | +66.7% |
| Q1 2019 | $359,000 | -7.7% | 4,413 | -25.4% | 0.14% | -50.0% |
| Q4 2018 | $389,000 | +2.4% | 5,913 | -0.7% | 0.29% | +16.6% |
| Q3 2018 | $380,000 | -13.0% | 5,956 | +0.7% | 0.25% | -22.8% |
| Q2 2018 | $437,000 | +13.5% | 5,913 | 0.0% | 0.32% | +9.6% |
| Q1 2018 | $385,000 | +0.8% | 5,913 | 0.0% | 0.29% | -9.6% |
| Q4 2017 | $382,000 | -48.5% | 5,913 | -50.0% | 0.32% | -0.3% |
| Q3 2017 | $742,000 | +107.3% | 11,826 | +100.0% | 0.32% | -18.0% |
| Q2 2017 | $358,000 | – | 5,913 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |